Meet the group

PharmAccess is a group of non-profit organizations dedicated to improving access to quality healthcare in Africa. PharmAccess mobilizes public and private resources for the benefit of doctors and patients through clinical standards and quality improvements, loans for healthcare providers, health insurance, mHealth innovations and operational research.

This integrated approach is made possible by the following organizations:

Visit website
Visit website
Visit website
Visit website
Country Offices

 Country Offices

 

Ghana
Kenya
Nigeria
Tanzania
Contact
  • Who we are
  • Our approach
  • News & Publications

PharmAccess Foundation
AHTC, Tower 4C
Paasheuvelweg 25
1105 BP Amsterdam
The Netherlands

T: +31 (0)20 2103920
E: info@pharmaccess.org

  • Who we are
  • Our approach
  • News & Publications
Newsroom

Philips and Medical Credit Fund announce partnership

Giving African clinics access to financing for medical equipment

  • Oct 17, 2014
Suggested reads
  • Dec 18, 2020
    Lagos state rolls out health insurance during pandemic, with technical assistance from Pharmaccess
  • Oct 28, 2019
    Quality HealthCare: The Pathway to Achieving Universal Health Coverage in Nigeria
  • Apr 24, 2019
    Public-Private partnerships - a game changer for the Nigerian health sector?

Amsterdam, Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) and the Medical Credit Fund, part of the PharmAccess Group, will be working together to improve access to quality healthcare in Africa. Through this partnership small and medium-sized private clinics in Africa have access to financing for innovative medical technologies and services from Philips. This enables clinics to expand and improve the quality of their services, giving more people access to quality healthcare.

Most small and medium-sized private clinics in Africa cannot obtain financing from banks due to the high investment risks. As a result, they are not able to invest in medical equipment, carry out necessary renovation works or recruit qualified personnel. At the same time these clinics serve more than half of the population in Africa, primarily low-income earners. The Medical Credit Fund is a Dutch fund that works with African banks to provide these clinics with affordable loans in their local currency. The loans are combined with management training and a quality improvement program called SafeCare that are implemented with local partners.

Every day some 800 women die as a result of complications that arise during pregnancy or childbirth. Many of these problems can be prevented if they are identified in time. It is one of the elements the partnership addresses. Midwives, for example, can have access to mobile ultrasound equipment which enables them to carry out relatively straightforward but critical examinations during pregnancy. The mobile ultrasound equipment can also be taken to rural villages to screen women that are not able to reach the clinics. The clinics will also be able to acquire patient monitoring and X-ray systems for the examination and treatment of patients.

Minister Lilianne Ploumen (Foreign Trade and Development Cooperation) believes access to quality healthcare in Africa is very important. This is why the Netherlands contributes to the Medical Credit Fund via the Dutch development bank FMO. Financing new healthcare technologies is an important component of improving healthcare delivery. “The partnership between the Medical Credit Fund and Philips shows clearly that aid and trade can work hand in hand. By working together, these parties can do even more to help improve healthcare delivery in Africa,” says Ploumen.

 

MCF-Philips contract

Minister Lilianne Ploumen (Foreign Trade and Development Cooperation) cited this partnership as a good example of aid and trade in her closing speech at the Africa Works! conference, after which Monique Dolfing-Vogelenzang and Philips’ Marc Bakker signed the contract
Photo: Rebke Klokke

Monique Dolfing-Vogelenzang, Managing Director Medical Credit Fund: “What we have seen is that clinics often use a loan to invest in medical equipment. It is therefore very important that quality equipment tailored to local circumstances is available on the market. With its knowledge of the African market, Philips is able to supply sustainable and innovative products that meet these needs, thus bringing about a structural improvement in the quality of healthcare.“

“Philips aims to contribute substantially to improving healthcare in Africa through innovative solutions that are tailored to local needs. Many clinics on the continent would like to invest in new medical technology, but find it difficult to obtain the necessary finance. Through this partnership we enable them to make good quality healthcare available to a large group of people who need healthcare. This also represents the next step in the further expansion of our activities in Africa,” says Peter van de Ven, General Manager of Philips Healthcare Africa.

The Medical Credit Fund works with the internationally recognized SafeCarestandards. The clinics enter a quality improvement program using these clinical standards that helps them to improve the quality and safety of their healthcare delivery. Thanks to this integrated approach of providing loans, training and improvement programs, the Medical Credit Fund enhances trust in the clinics among both patients and financial institutions, and is helping to build effective healthcare systems in sub-Saharan Africa.

The partnership will initially involve the countries in which the Medical Credit Fund already operates, i.e. Ghana, Kenya, Nigeria and Tanzania. So far the Medical Credit Fund has provided more than USD 6 million in loans to small African clinics, with a repayment rate of over 97%. More than 500 clinics are already using these loans to improve the quality of the healthcare they provide.

For further information contact:
Joost Maltha
Philips Benelux
Tel. +31 6 10 55 8116
E-mail: joost.maltha@philips.com

Charlotte Wagenaar
PharmAccess / Medical Credit Fund
Tel. +31 6 34 99 56 16
E-mail: c.wagenaar@pharmaccess.org
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 113,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

About the Medical Credit Fund
The Medical Credit Fund (MCF) facilitates SME loans to private primary healthcare providers through local banks. This finance program is combined with internationally certified clinical (SafeCare) and business technical assistance programs to ensure that funding is well spent. Together the loans and support program will help to improve the quality of the health clinics which will lead to expanded and improved healthcare services for more people.

The MCF is an initiative of PharmAccess International. In November 2010, the Fund won the G-20 SME Finance Challenge. What makes the Fund especially innovative is its ‘layered capital’ structure. By using philanthropic capital to catalyze much larger amounts of funding from private and public sources, the MCF is able to increase its developmental impact significantly. The Dutch government has played an important role by providing a guarantee and financing for the technical assistance through the Dutch development bank FMO. The MCF investors are (amongst others) OPIC, Gates Foundation, Soros, USAID, IFC, and the Dutch Ministry of Foreign Affairs. In 2014, MCF was awarded second place in the SME Finance Innovation Award, and won an OPIC Impact Award in the category Access to Finance. www.medicalcreditfund.org

Share
Tags: Amsterdam MCF Medical Credit Fund PharmAccess Philips
Quickly go to
  • Home
  • Management & Board
  • Our partners
  • Reporting
  • Vacancies
  • Contact
  • Publications
Follow us
  • Twitter
  • Linkedin
  • Facebook
  • Home
  • Management & Board
  • Our partners
  • Reporting
  • Vacancies
  • Contact
  • Publications
  • Kenya
  • Nigeria
  • Ghana
  • Tanzania
  • Twitter
  • Linkedin
  • PharmAccess@Medium
  • Disclaimer
  • Privacy statement
  • © 2022 PharmAccess Group. All rights reserved.
Our COVID-19 response
To serve you better and more personal we make use of cookies.

Accept
Read more
Change Settings
Cookie Box Settings privacy settings
Cookie Box Settings privacy settings

Privacy settings

Decide which cookies you want to allow. You can change these settings at any time. However, this can result in some functions no longer being available. For information on deleting the cookies, please consult your browser’s help function. Learn more about the cookies we use via our privacy statement.

With the slider, you can enable or disable different types of cookies:

  • Block all
  • Essential
  • Functionality
  • Analytics

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected

This website won't:

  • Remember your login details
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country

This website won't:

  • Remember your login details
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions

This website won't:

  • Remember your login details
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sites
  • Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sitesl Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website won't:

  • Remember your login details
Save & Close